Posts by: Jose Marques Lopes, PhD

Bayer’s Adempas (riociguat) can improve the lung and heart functioning of pulmonary hypertension patients who fail to respond to phosphodiesterase-5 inhibitors (PDE5i), a Phase 3 clinical trial suggests. The RESPITE trial ... Read more

September 12, 2017September 12, 2017

Uptravi Improves Connective Tissue Disease-Associated PAH, Regardless of Disease Subtype, Trial Shows

News, PAH News

Uptravi (selexipag) slows the progression of connective tissue disease associated with pulmonary arterial hypertension, regardless of the type of connective tissue disease, according to a Phase 3 clinical trial in ... Read more

June 15, 2017June 15, 2017

Early Renal Denervation Improves Pulmonary Hypertension and Survival Rate, Animal Study Shows

News

Early renal denervation (RDN) treatment improved pulmonary arterial hypertension (PAH) in a rat model, a new study from China showed. The study titled, “Effects of renal denervation on monocrotaline induced pulmonary remodeling,” ... Read more

April 11, 2017April 11, 2017

Pulmonary Hypertension Patients Like Implanted Remodulin Delivery System

News, PAH News

Pulmonary arterial hypertension (PAH) patients have given high marks to a new implanted, programmable intravenous (IV) system that delivered Remodulin (treprostinil) to them with few complications, according to a clinical ... Read more

March 31, 2017March 31, 2017

Pulmonary Thromboendarterectomy Should Be Considered for PH Before Transplant, Case Report Contends

CTEPH News, News, PH News

Chronic thromboembolic pulmonary hypertension (CTEPH) may be mitigated by pulmonary thromboendarterectomy, which prevents the need for lung transplant, a new case report shows. The study, “Pulmonary Thromboendarterectomy for Pulmonary ... Read more

March 24, 2017March 24, 2017

SOD2 Gene Variation Associated with Susceptibility to PAH, Chinese Study Shows

News, PAH News

A variation in the gene sequence of superoxide dismutase 2 (SOD2) is associated with a susceptibility to pulmonary arterial hypertension (PAH), new research from China shows. SOD2 is an antioxidant enzyme ... Read more

March 20, 2017March 20, 2017

Study of Long-term Survival Among PAH Patients in Portugal Shows Progress of Recent Decades

News, PAH News

People newly diagnosed with pulmonary arterial hypertension (PAH) in Portugal have survival rates similar to those in other developed countries — and much better than the life expectancy of PAH patients ... Read more